Trial Profile
A Phase-III multicentric randomized open label, active Controlled study to evaluate the Immunogenicity and Safety of BBILs combination of DTwPHib (Comvac4) vaccine in comparison with Reference Vaccine Comvac3â?¢ BioHib in healthy infants of 6 to 7 weeks age - Comvac4
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs DTP-hepatitis B vaccine (Primary)
- Indications Diphtheria; Hepatitis B; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Bharat Biotech
- 08 Jan 2018 Status changed from not yet recruiting to completed.
- 14 Feb 2017 New trial record